Sansure Biotech Salute del bilancio
Salute finanziaria criteri di controllo 5/6
Sansure Biotech has a total shareholder equity of CN¥7.4B and total debt of CN¥409.8M, which brings its debt-to-equity ratio to 5.6%. Its total assets and total liabilities are CN¥8.6B and CN¥1.2B respectively. Sansure Biotech's EBIT is CN¥41.2M making its interest coverage ratio -0.5. It has cash and short-term investments of CN¥4.6B.
Informazioni chiave
5.6%
Rapporto debito/patrimonio netto
CN¥409.76m
Debito
| Indice di copertura degli interessi | -0.5x |
| Contanti | CN¥4.57b |
| Patrimonio netto | CN¥7.35b |
| Totale passività | CN¥1.22b |
| Totale attività | CN¥8.57b |
Aggiornamenti recenti sulla salute finanziaria
Recent updates
Sansure Biotech's (SHSE:688289) Problems Go Beyond Weak Profit
Nov 03
Sansure Biotech Inc.'s (SHSE:688289) 39% Price Boost Is Out Of Tune With Earnings
Oct 09Sansure Biotech (SHSE:688289) Could Be Struggling To Allocate Capital
Oct 03Is Sansure Biotech (SHSE:688289) A Risky Investment?
Sep 12Sansure Biotech Inc. (SHSE:688289) Investors Are Less Pessimistic Than Expected
Aug 21Sansure Biotech (SHSE:688289) May Have Issues Allocating Its Capital
Jun 03Why Sansure Biotech's (SHSE:688289) Soft Earnings Are Just The Beginning Of Its Problems
May 03Sansure Biotech Inc.'s (SHSE:688289) Business Is Trailing The Industry But Its Shares Aren't
Apr 26Sansure Biotech's (SHSE:688289) Returns On Capital Are Heading Higher
Feb 28Analisi della posizione finanziaria
Passività a breve termine: 688289's short term assets (CN¥5.7B) exceed its short term liabilities (CN¥714.3M).
Passività a lungo termine: 688289's short term assets (CN¥5.7B) exceed its long term liabilities (CN¥503.8M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 688289 has more cash than its total debt.
Riduzione del debito: 688289's debt to equity ratio has increased from 0% to 5.6% over the past 5 years.
Copertura del debito: 688289's debt is well covered by operating cash flow (49.6%).
Copertura degli interessi: 688289 earns more interest than it pays, so coverage of interest payments is not a concern.